Cytokine‑Armored CAR T Cells Overcome Antigen Heterogeneity in Glioma Model
Scientists developed a cytokine-armored CAR T-cell therapy that helps the immune system better attack aggressive brain tumors in mice, which they paired with a CAR T strategy targeting VEGF that helps reduce side effects while preserving strong anti-tumor activity. The post Cytokine‑Armored CAR T Cells Overcome Antigen Heterogeneity in Glioma Model appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.